Compare
VADs
Functional
Generations 4 & 5
|
Press
Release
MicroMed Cardiovascular Selected Among Top Companies
by Nation’s Largest Venture Capital Competition
Houston Manufacturer of HeartAssist 5™ Left Ventricular Assist Device
Chosen #1 in Region and Among National Finalists
HOUSTON – Oct. 20, 2009 – On Oct. 8, MicroMed Cardiovascular (www.micromedcv.com), manufacturer of the HeartAssist 5™ left ventricular assist device (LVAD), was selected as one of the Top 50 Emerging Companies in the nation’s largest venture capital competition, the Sixth Annual Pitching Across America competition.
“More than 100 VCs and Angel Investors voted us as one of the most promising companies and technologies out there,” said Bill Birdsall, MicroMed CEO. “The HeartAssist 5 is designed to help the heart’s failing left ventricle by pumping up to 10 L/min of blood to the body.”
Judging criteria consisted of several key points including: current stage of development (customers, revenue), competitive advantage, need in the marketplace and whether the company is "VentureWorthy."
The HeartAssist 5 pump weighs 92 grams and measures 2.8 x 1.2 inches. Because of its miniature size, it is one of the few LVADs that can be implanted above the diaphragm, adjacent to the heart. The HeartAssist 5 is the only LVAD with a precise, direct flow measurement system.
For more information, please visit http://www.micromedcv.com
###
In Europe, the DeBakey VAD® has CE Marks for both adult and pediatric use. In the U.S., the DeBakey VAD® Child is the only FDA-approved pediatric VAD. An IDE clinical study is currently underway in the U.S. for adults.
Media Contact:
Don
Isaacs
Director of Communications
MicroMed
Cardiovascular
Cell: (520) 955-0660
Resources for Reporters
|
